HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Tomás Reinert Selected Research
Tomás Reinert Research Topics
Disease
24
Breast Neoplasms (Breast Cancer)
09/2023 - 01/2016
16
Neoplasms (Cancer)
11/2023 - 12/2016
2
Triple Negative Breast Neoplasms
11/2023 - 01/2020
2
Disease Progression
01/2018 - 11/2017
1
Fatigue
01/2020
1
Vomiting
01/2020
1
Nausea
01/2020
1
Sleep Initiation and Maintenance Disorders (Insomnia)
01/2020
1
Neoplasm Metastasis (Metastasis)
01/2019
1
Renal Cell Carcinoma (Grawitz Tumor)
07/2016
Drug/Important Bio-Agent (IBA)
9
Hormones (Hormone)
IBA
09/2023 - 01/2016
8
Estrogen Receptors
IBA
11/2022 - 10/2017
6
Phenobarbital (Luminal)
FDA Link
09/2023 - 12/2016
4
Biomarkers (Surrogate Marker)
IBA
09/2023 - 01/2019
3
ErbB Receptors (EGF Receptor)
IBA
11/2022 - 12/2016
3
Trastuzumab (Herceptin)
FDA Link
01/2019 - 06/2017
2
ribociclib
IBA
01/2022 - 01/2020
2
pertuzumab
IBA
01/2018 - 06/2017
1
Biosimilar Pharmaceuticals
IBA
11/2023
1
Carboplatin (JM8)
FDA Link
Generic
11/2023
1
Androgen Receptors (Androgen Receptor)
IBA
09/2023
1
Epidermal Growth Factor (EGF)
IBA
12/2021
1
Biological Factors
IBA
01/2021
1
Aromatase Inhibitors
IBA
01/2020
1
Formaldehyde (Formol)
FDA Link
01/2019
1
Paraffin
IBA
01/2019
1
Lapatinib (GW572016)
FDA Link
01/2018
1
Cyclin-Dependent Kinases (cdk Proteins)
IBA
01/2018
1
human ERBB2 protein
IBA
06/2017
1
Sunitinib (Sutent)
FDA Link
07/2016
Therapy/Procedure
20
Therapeutics
09/2023 - 01/2016
5
Neoadjuvant Therapy
11/2023 - 12/2016
2
Drug Therapy (Chemotherapy)
01/2020 - 01/2019